Takara Bio Inc. (4974.T)
JPY 781.0
(0.0%)
JPY 781.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -32.2 Billion JPY | 36.7% |
| 2022 | -50.87 Billion JPY | -125.25% |
| 2021 | -22.58 Billion JPY | 9.12% |
| 2020 | -24.85 Billion JPY | -44.94% |
| 2019 | -17.14 Billion JPY | -0.66% |
| 2018 | -17.03 Billion JPY | 2.87% |
| 2017 | -17.53 Billion JPY | 37.25% |
| 2016 | -27.94 Billion JPY | -45.64% |
| 2015 | -19.19 Billion JPY | 5.69% |
| 2014 | -20.34 Billion JPY | 2.83% |
| 2013 | -20.94 Billion JPY | -16.92% |
| 2012 | -17.91 Billion JPY | -2.42% |
| 2011 | -17.48 Billion JPY | -2.74% |
| 2010 | -17.02 Billion JPY | -27.89% |
| 2009 | -13.3 Billion JPY | -57.83% |
| 2008 | -8.43 Billion JPY | -4.0% |
| 2007 | -8.1 Billion JPY | -77.19% |
| 2006 | -4.57 Billion JPY | 28.84% |
| 2005 | -6.43 Billion JPY | 46.77% |
| 2004 | -12.08 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -35.59 Billion JPY | -10.55% |
| 2023 Q1 | -44.83 Billion JPY | 11.87% |
| 2023 FY | -32.2 Billion JPY | 36.7% |
| 2023 Q3 | -34.16 Billion JPY | 8.24% |
| 2023 Q4 | -32.2 Billion JPY | 5.75% |
| 2023 Q2 | -37.23 Billion JPY | 16.95% |
| 2022 Q4 | -50.87 Billion JPY | -73.2% |
| 2022 Q2 | -25.16 Billion JPY | -13.3% |
| 2022 Q1 | -22.21 Billion JPY | 1.65% |
| 2022 FY | -50.87 Billion JPY | -125.25% |
| 2022 Q3 | -29.37 Billion JPY | -16.71% |
| 2021 Q1 | -30.03 Billion JPY | -20.84% |
| 2021 Q2 | -31.14 Billion JPY | -3.7% |
| 2021 Q3 | -33.93 Billion JPY | -8.97% |
| 2021 FY | -22.58 Billion JPY | 9.12% |
| 2021 Q4 | -22.58 Billion JPY | 33.44% |
| 2020 Q3 | -21.85 Billion JPY | -17.34% |
| 2020 Q2 | -18.62 Billion JPY | 5.66% |
| 2020 FY | -24.85 Billion JPY | -44.94% |
| 2020 Q1 | -19.74 Billion JPY | -15.16% |
| 2020 Q4 | -24.85 Billion JPY | -13.71% |
| 2019 Q4 | -17.14 Billion JPY | 0.79% |
| 2019 Q3 | -17.28 Billion JPY | 4.68% |
| 2019 FY | -17.14 Billion JPY | -0.66% |
| 2019 Q2 | -18.13 Billion JPY | 8.38% |
| 2019 Q1 | -19.79 Billion JPY | -16.19% |
| 2018 Q4 | -17.03 Billion JPY | 6.32% |
| 2018 Q3 | -18.18 Billion JPY | 4.86% |
| 2018 FY | -17.03 Billion JPY | 2.87% |
| 2018 Q2 | -19.11 Billion JPY | -2.26% |
| 2018 Q1 | -18.68 Billion JPY | -6.57% |
| 2017 Q3 | -14.61 Billion JPY | -0.1% |
| 2017 Q2 | -14.59 Billion JPY | -4.08% |
| 2017 Q1 | -14.02 Billion JPY | 49.82% |
| 2017 FY | -17.53 Billion JPY | 37.25% |
| 2017 Q4 | -17.53 Billion JPY | -20.03% |
| 2016 Q2 | -24.32 Billion JPY | -25.65% |
| 2016 Q3 | -23.15 Billion JPY | 4.83% |
| 2016 FY | -27.94 Billion JPY | -45.64% |
| 2016 Q1 | -19.36 Billion JPY | -0.89% |
| 2016 Q4 | -27.94 Billion JPY | -20.71% |
| 2015 Q3 | -18.87 Billion JPY | 0.53% |
| 2015 Q1 | -20.07 Billion JPY | 1.35% |
| 2015 FY | -19.19 Billion JPY | 5.69% |
| 2015 Q2 | -18.97 Billion JPY | 5.45% |
| 2015 Q4 | -19.19 Billion JPY | -1.65% |
| 2014 Q3 | -17.32 Billion JPY | 7.79% |
| 2014 Q2 | -18.78 Billion JPY | 17.04% |
| 2014 Q1 | -22.64 Billion JPY | -8.13% |
| 2014 Q4 | -20.34 Billion JPY | -17.47% |
| 2014 FY | -20.34 Billion JPY | 2.83% |
| 2013 FY | -20.94 Billion JPY | -16.92% |
| 2013 Q2 | -24.58 Billion JPY | -38.45% |
| 2013 Q1 | -17.75 Billion JPY | 0.85% |
| 2013 Q4 | -20.94 Billion JPY | 7.68% |
| 2013 Q3 | -22.68 Billion JPY | 7.74% |
| 2012 Q3 | -16.67 Billion JPY | 6.12% |
| 2012 Q1 | -17.66 Billion JPY | -0.99% |
| 2012 Q2 | -17.76 Billion JPY | -0.59% |
| 2012 Q4 | -17.91 Billion JPY | -7.39% |
| 2012 FY | -17.91 Billion JPY | -2.42% |
| 2011 Q3 | -17.77 Billion JPY | 1.41% |
| 2011 Q4 | -17.48 Billion JPY | 1.64% |
| 2011 Q1 | -17.67 Billion JPY | -3.86% |
| 2011 FY | -17.48 Billion JPY | -2.74% |
| 2011 Q2 | -18.03 Billion JPY | -2.01% |
| 2010 Q2 | -14.24 Billion JPY | -0.94% |
| 2010 Q4 | -17.02 Billion JPY | -14.54% |
| 2010 Q3 | -14.85 Billion JPY | -4.3% |
| 2010 Q1 | -14.11 Billion JPY | -6.06% |
| 2010 FY | -17.02 Billion JPY | -27.89% |
| 2009 Q3 | -11.66 Billion JPY | 0.91% |
| 2009 FY | -13.3 Billion JPY | -57.83% |
| 2009 Q4 | -13.3 Billion JPY | -14.12% |
| 2009 Q2 | -11.76 Billion JPY | 0.0% |
| 2008 Q4 | -8.43 Billion JPY | 0.0% |
| 2008 FY | -8.43 Billion JPY | -4.0% |
| 2007 FY | -8.1 Billion JPY | -77.19% |
| 2006 FY | -4.57 Billion JPY | 28.84% |
| 2005 FY | -6.43 Billion JPY | 46.77% |
| 2004 FY | -12.08 Billion JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 742.75 Million JPY | 4435.592% |
| PRISM BioLab Co.,LTD | -1.13 Billion JPY | -2739.913% |
| GNI Group Ltd. | -17.93 Billion JPY | -79.568% |
| Linical Co., Ltd. | -4.46 Billion JPY | -621.508% |
| Trans Genic Inc. | -221.16 Million JPY | -14460.359% |
| MEDINET Co., Ltd. | -4.39 Billion JPY | -632.881% |
| Soiken Holdings Inc. | -4.79 Billion JPY | -572.293% |
| Cytori Cell Research Institute, Inc. | 1.43 Billion JPY | 2346.402% |
| AnGes, Inc. | -3.79 Billion JPY | -747.95% |
| OncoTherapy Science, Inc. | -420.8 Million JPY | -7552.677% |
| Nxera Pharma Co., Ltd. | 24.9 Billion JPY | 229.288% |
| Immuno-Biological Laboratories Co., Ltd. | -498.15 Million JPY | -6364.467% |
| NanoCarrier Co., Ltd. | -466.34 Million JPY | -6805.373% |
| Carna Biosciences, Inc. | -2.7 Billion JPY | -1090.002% |
| CanBas Co., Ltd. | -1.88 Billion JPY | -1605.487% |
| D. Western Therapeutics Institute, Inc. | -982.14 Million JPY | -3178.854% |
| RaQualia Pharma Inc. | -3.39 Billion JPY | -847.978% |
| Chiome Bioscience Inc. | -1.03 Billion JPY | -3012.742% |
| Kidswell Bio Corporation | 343.58 Million JPY | 9472.535% |
| PeptiDream Inc. | 3.29 Billion JPY | 1078.222% |
| Oncolys BioPharma Inc. | -972.59 Million JPY | -3211.046% |
| Ribomic Inc. | -2.09 Billion JPY | -1433.664% |
| SanBio Company Limited | -3.78 Billion JPY | -749.747% |
| Healios K.K. | -2.19 Billion JPY | -1370.457% |
| BrightPath Biotherapeutics Co., Ltd. | -944.85 Million JPY | -3308.23% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -2.62 Billion JPY | -1127.18% |
| Delta-Fly Pharma, Inc. | -1.41 Billion JPY | -2172.519% |
| StemRIM | -8.41 Billion JPY | -282.913% |
| CellSource Co., Ltd. | -4.68 Billion JPY | -587.587% |
| FunPep Company Limited | -1.79 Billion JPY | -1695.662% |
| Kringle Pharma, Inc. | -2.13 Billion JPY | -1407.285% |
| Stella Pharma Corporation | -1.11 Billion JPY | -2776.799% |
| TMS Co., Ltd. | -3.44 Billion JPY | -834.333% |
| Noile-Immune Biotech Inc. | -5.55 Billion JPY | -479.64% |
| Cuorips Inc. | -5.56 Billion JPY | -479.086% |
| K Pharma,Inc. | -3.26 Billion JPY | -885.884% |
| ReproCELL Incorporated | -2.93 Billion JPY | -995.692% |
| PhoenixBio Co., Ltd. | -660.96 Million JPY | -4772.156% |
| StemCell Institute Inc. | -2.83 Billion JPY | -1035.205% |
| Japan Tissue Engineering Co., Ltd. | -2.06 Billion JPY | -1458.453% |
| CellSeed Inc. | -2.01 Billion JPY | -1500.513% |